Adam Spice - Nov 25, 2022 Form 4 Insider Report for Rocket Lab USA, Inc. (RKLB)

Role: Chief Financial Officer
Signature: /s/ Janine Wong as Attorney-in-Fact for Adam Spice
Stock symbol: RKLB
Transactions as of: Nov 25, 2022
Transactions value $: -$192,681
Form type: 4
Date filed: 11/29/2022, 03:56 PM
Previous filing: Aug 26, 2022
Next filing: Mar 13, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RKLB	Common Stock	Sale	-$193K	-45.7K	-2.54%	$4.22	1.75M	Nov 25, 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the reporting person.
F2	The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.14 to $4.525, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Content

Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the reporting person.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.14 to $4.525, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.